Showing 761 - 780 results of 216,838 for search '(( 1 1 decrease ) OR ( 5 ((((point decrease) OR (fold decrease))) OR (a decrease)) ))', query time: 2.51s Refine Results
  1. 761
  2. 762

    Image_1_IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients.tif by Marzia Spagnardi (9330602)

    Published 2022
    “…A significant decrease in the response to 5-FU treatment, as well as a significant increase in phosphorylation of IκBα and secretion of IL-8, was seen following IL-1β treatment, in both AA and CA cell lines. …”
  3. 763

    Image_2_IL-1β enhances cell viability and decreases 5-FU sensitivity in novel colon cancer cell lines derived from African American patients.tif by Marzia Spagnardi (9330602)

    Published 2022
    “…A significant decrease in the response to 5-FU treatment, as well as a significant increase in phosphorylation of IκBα and secretion of IL-8, was seen following IL-1β treatment, in both AA and CA cell lines. …”
  4. 764
  5. 765
  6. 766
  7. 767
  8. 768
  9. 769
  10. 770

    S1 Data - by Mahmoud A. Alomari (14780446)

    Published 2023
    Subjects:
  11. 771
  12. 772
  13. 773
  14. 774

    Hydroxyl Defects in LiFePO<sub>4</sub> Cathode Material: DFT+<i>U</i> and an Experimental Study by Dmitry A. Aksyonov (4918594)

    Published 2021
    “…Using a combined computational and experimental approach comprising density functional theory (DFT)+<i>U</i> and molecular dynamics calculations and X-ray and neutron diffraction, we provide a comprehensive characterization of various OH point defects in LiFePO<sub>4</sub>, including their formation, dynamics, and localization in the interstitial space and at Li, Fe, and P sites. …”
  15. 775

    Discovery of a Colon-Targeted Azo Prodrug of Tofacitinib through the Establishment of Colon-Specific Delivery Systems Constructed by 5‑ASA–PABA–MAC and 5‑ASA–PABA–Diamine for the T... by Jiaxing Zhao (3965057)

    Published 2022
    “…Specifically, compound <b>20g</b> displayed a 3.67-fold decrease of plasma AUC<sub>(tofacitinib, 0–∞)</sub> and a 9.61-fold increase of colonic AUC<sub>(tofacitinib, 0–12h)</sub>, compared with tofacitinib at a molar equivalent oral dose. …”
  16. 776
  17. 777
  18. 778
  19. 779
  20. 780